Inhalon Doses First Patient in Phase 1 Study of Inhaled IN-006 to Treat COVID-19
/PRNewswire/ -- Inhalon Biopharma, Inc., a clinical-stage immunotherapy company developing an inhaled "muco-trapping" antibody platform for treating acute...
Source: prnewswire.com